CINVEN LIMITED

CINVEN LIMITED

Cinven was founded in 1977 as a spin-out from the UK's British Coal Pension Funds, becoming one of Europe's earliest dedicated private equity firms. The firm has since operated independently, raising capital from institutional investors globally. Cinven targets control-oriented buyouts and build-up acquisitions in six core sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media & Telecom. The firm invests across a range of company sizes, typically requiring €100 million or more in equity per deal. Known investments include the acquisition of the pharmaceutical company Stada Arzneimittel in 2017 alongside Bain Capital (per The Wall Street Journal, 2017). Cinven also acquired the global compliance and risk management business from The Dun & Bradstreet Corporation in 2020. The firm's geographic focus spans Western and Central Europe, with additional reach into North America and Asia through its New York, Hong Kong, Shanghai, and Tokyo offices. Cinven employs around 100 investment professionals across nine offices in London, Paris, Frankfurt, Milan, Madrid, Luxembourg, New York, Hong Kong, Shanghai, and Tokyo. The firm has raised several vintages of its flagship European buyout fund, most recently Cinven VIII, which closed at its hard cap in 2019. In 2021, Cinven announced the closing of its first dedicated direct-lending fund, Cinven Credit Partners I, with €1.2 billion in commitments (per the firm, 2021). Cinven's structural differentiator is its deep sector-specialist model, where investment teams operate within dedicated sector verticals, supported by a centralized portfolio-operations group. The firm also maintains a substantial co-investment program, allowing select LPs to participate alongside the main fund investments.